Spectrum Wealth Counsel »

Crispr Therapeutics shares owned by Spectrum Wealth Counsel

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Spectrum Wealth Counsel from 13F filings

Historical chart of Spectrum Wealth Counsel investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Spectrum Wealth Counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Spectrum Wealth Counsel

Quarter filed Position value Share count Share price at filing
2024-03-31 $273 4 68.25
2023-12-31 $25k 404 62.60

More positions owned by Spectrum Wealth Counsel

Spdr S&p 500 Etf Tr Put Put Option (Principal) (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Select Sector Spdr Tr Technology (XLK)
Microsoft Corporation (MSFT)
First Tr Exchange-traded Ft Vest Ris (RDVI)
Apple (AAPL)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Eafe Value Etf (EFV)
Eli Lilly & Co Call Call Option (Principal) (LLY)
Ishares Tr Core Total Usd (IUSB)
Broadcom (AVGO)
TJX Companies (TJX)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)

View all positions for Spectrum Wealth Counsel

Top funds holding Crispr Therapeutics

ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
BlackRock
Citadel Advisors
Vanguard Group
NEA Management Company
Susquehanna International
Caption Management
Dimensional Fund Advisors
Bellevue Group
T. Rowe Price Associates
Bank of America Corporation
Voloridge Investment Management
Ikarian Capital

View all funds holding Crispr Therapeutics